Gebruikersprofielen voor "Kahn, R.S. "

Robert S. Kahn

Cincinnati
Geverifieerd e-mailadres voor cchmc.org
Geciteerd door 11945

Dopamine in schizophrenia: a review and reconceptualization.

KL Davis, RS Kahn, G Ko… - The American journal of …, 1991 - europepmc.org
Objective The initial hypothesis that schizophrenia is a manifestation of hyperdopaminergia
has recently been faulted. However, several new findings suggest that abnormal, although …

Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies

AM Hedman, NEM van Haren, HG Schnack… - Human brain …, 2012 - Wiley Online Library
There is consistent evidence that brain volume changes in early and late life. Most longitudinal
studies usually only span a few years and include a limited number of participants. In this …

Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis

JV Zorn, RR Schür, MP Boks, RS Kahn, M Joëls… - …, 2017 - Elsevier
The hypothalamus-pituitary-adrenal (HPA) axis and its end product cortisol are essential for
an adequate response to stress. Considering the role of stress as a risk factor for psychiatric …

Brain volume abnormalities in major depressive disorder: A meta‐analysis of magnetic resonance imaging studies

PCMP Koolschijn, NEM van Haren… - Human brain …, 2009 - Wiley Online Library
Objective. So far, there have been no attempts to integrate the growing number of all brain
volumetric magnetic resonance imaging studies in depression. In this comprehensive meta‐…

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children

TE Froehlich, BP Lanphear, JN Epstein… - … of pediatrics & …, 2007 - jamanetwork.com
Objective To determine the US national prevalence of attention-deficit/hyperactivity disorder
(ADHD) and whether prevalence, recognition, and treatment vary by socioeconomic group. …

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)

M Davidson, S Galderisi, M Weiser… - American Journal of …, 2009 - Am Psychiatric Assoc
Objective: Cognitive impairment, manifested as mild to moderate deviations from psychometric
norms, is present in many but not all schizophrenia patients. The purpose of the present …

[HTML][HTML] Biological insights from 108 schizophrenia-associated genetic loci

S Ripke, BM Neale, A Corvin, JTR Walters, KH Farh… - Nature, 2014 - ncbi.nlm.nih.gov
Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of
alleles, including common alleles of small effect that might be detected by genome-wide …

Rare coding variants in ten genes confer substantial risk for schizophrenia

T Singh, T Poterba, D Curtis, H Akil, M Al Eissa… - Nature, 2022 - nature.com
Rare coding variation has historically provided the most direct connections between gene
function and disease pathogenesis. By meta-analysing the whole exomes of 24,248 …

[HTML][HTML] Brain charts for the human lifespan

RAI Bethlehem, J Seidlitz, SR White, JW Vogel… - Nature, 2022 - nature.com
Over the past few decades, neuroimaging has become a ubiquitous tool in basic research
and clinical studies of the human brain. However, no reference standards currently exist to …

Memory impairment in schizophrenia: a meta-analysis

A Aleman, R Hijman, EHF De Haan… - American Journal of …, 1999 - Am Psychiatric Assoc
OBJECTIVE: Memory impairment is well documented in schizophrenia. Less is known, however,
about the exact magnitude, pattern, and extent of the impairment. The effect of potential …